These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32230890)
1. Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating LPA Receptor/PKC Pathway. Won KJ; Goh YJ; Hwang SH Molecules; 2020 Mar; 25(7):. PubMed ID: 32230890 [TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid (LPA) as a modulator of plasma membrane Ca Sant'Anna JF; Baldez VS; Razuck-Garrão NA; Lemos T; Diaz BL; Einicker-Lamas M J Physiol Biochem; 2021 May; 77(2):321-329. PubMed ID: 33704695 [TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway. Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791 [TBL] [Abstract][Full Text] [Related]
4. Proinsulin C-Peptide Enhances Cell Survival and Protects against Simvastatin-Induced Myotoxicity in L6 Rat Myoblasts. Essid SM; Bevington A; Brunskill NJ Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987105 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells. Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008 [TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis. Zhao J; Wei J; Weathington N; Jacko AM; Huang H; Tsung A; Zhao Y Transl Res; 2015 Jul; 166(1):80-8. PubMed ID: 25701366 [TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor. Woclawek-Potocka I; Kondraciuk K; Skarzynski DJ Exp Biol Med (Maywood); 2009 Aug; 234(8):986-93. PubMed ID: 19491366 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol for protection against statin toxicity in C2C12 and H9c2 cells. Attalah Nee Rezkallah C; Thongkum A; Zhu C; Chen QM J Biochem Mol Toxicol; 2020 Jun; 34(6):e22484. PubMed ID: 32196851 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid enhances human umbilical cord mesenchymal stem cell viability without differentiation via LPA receptor mediating manner. Li N; Yan YL; Fu S; Li RJ; Zhao PF; Xu XY; Yang JP; Damirin A Apoptosis; 2017 Oct; 22(10):1296-1309. PubMed ID: 28766061 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid induces erythropoiesis through activating lysophosphatidic acid receptor 3. Chiang CL; Chen SS; Lee SJ; Tsao KC; Chu PL; Wen CH; Hwang SM; Yao CL; Lee H Stem Cells; 2011 Nov; 29(11):1763-73. PubMed ID: 21915944 [TBL] [Abstract][Full Text] [Related]
12. TNF-α potentiates lysophosphatidic acid-induced COX-2 expression via PKD in human colonic myofibroblasts. Rodriguez Perez CE; Nie W; Sinnett-Smith J; Rozengurt E; Yoo J Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G637-46. PubMed ID: 21292998 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid signaling promotes proliferation, differentiation, and cell survival in rat growth plate chondrocytes. Hurst-Kennedy J; Boyan BD; Schwartz Z Biochim Biophys Acta; 2009 May; 1793(5):836-46. PubMed ID: 19233232 [TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid-stimulated interleukin-6 and -8 synthesis through LPA1 receptors on human osteoblasts. Aki Y; Kondo A; Nakamura H; Togari A Arch Oral Biol; 2008 Mar; 53(3):207-13. PubMed ID: 17915188 [TBL] [Abstract][Full Text] [Related]
15. The protective effect of Herba Cistanches on statin-induced myotoxicity in vitro. Wat E; Ng CF; Koon CM; Wong EC; Tomlinson B; Lau CB J Ethnopharmacol; 2016 Aug; 190():68-73. PubMed ID: 27286913 [TBL] [Abstract][Full Text] [Related]
16. Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. Kaneyuki U; Ueda S; Yamagishi S; Kato S; Fujimura T; Shibata R; Hayashida A; Yoshimura J; Kojiro M; Oshima K; Okuda S Vascul Pharmacol; 2007 Apr; 46(4):286-92. PubMed ID: 17178255 [TBL] [Abstract][Full Text] [Related]
17. Dioleoyl phosphatidic acid increases intracellular Ca2+ through endogenous LPA receptors in C6 glioma and L2071 fibroblasts. Chang YJ; Kim YL; Lee YK; Sacket SJ; Kim K; Kim HL; Han M; Bae YS; Okajima F; Im DS Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):268-76. PubMed ID: 17499746 [TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid induces exocytic trafficking of Na(+)/H(+) exchanger 3 by E3KARP-dependent activation of phospholipase C. Choi JW; Lee-Kwon W; Jeon ES; Kang YJ; Kawano K; Kim HS; Suh PG; Donowitz M; Kim JH Biochim Biophys Acta; 2004 Jul; 1683(1-3):59-68. PubMed ID: 15238220 [TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid upregulates connective tissue growth factor expression in osteoblasts through the GPCR/PKC and PKA pathways. Yu ZL; Li DQ; Huang XY; Xing X; Yu RQ; Li Z; Li ZB Int J Mol Med; 2016 Feb; 37(2):468-74. PubMed ID: 26743816 [TBL] [Abstract][Full Text] [Related]
20. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]